Alendene is a drug used to treat osteoporosis in postmenopausal women. It aims to prevent and reduce the risk of developing this condition in women, especially when the risk of developing it is high. It also enhances bone density in men. In addition,
Alendene treats osteoporosis in both men and women resulting from the use of steroids such as cortisone. The treatment also includes Paget's disease of the bone.